University Of Southampton

University Of Southampton, a UK-based international research institution, acts as a prime recipient on federal research and development grants in aeronautical science, astronautical science, and advanced materials engineering, with subordinate subrecipient roles on biomedical research grants from U.S. institutional prime awardees. The institution does not hold federal contracts or contract vehicles; all federal activity is grant-funded.

Southampton's federal funding footprint centers on defense and national security research. The Department of the Air Force dominates by award count (24 awards, 71% of total awards across top five customers), followed by the Department of the Navy (12 combined awards across two organizational lines) and the Department of the Army (6 awards). However, the Dollar rankings diverge sharply: a single Defense Advanced Research Projects Agency grant carries $1.3 million in combined potential value, dwarfing the cumulative Air Force awards. Across 66 total awards spanning 18 distinct agencies, Southampton has received $18.1 million in obligated dollars against a combined potential value of $1.6 million — a 1,142% ratio reflecting grants already substantially drawn down and completed.

Recent grant work as a prime recipient includes a $137,478 Air Force Defense Research Sciences Program (CFDA 12.800) award issued April 1, 2024 (ultimate completion March 31, 2025) supporting research and development in aeronautical science; a $199,932 Air Force Defense Research Sciences Program award issued August 1, 2023 (ultimate completion July 31, 2026) for astronautical science and engineering; and a multi-year Air Force grant issued May 15, 2023 (ultimate completion May 14, 2028) for aeronautical R&D on turbulence modeling over surface roughness changes. Southampton is also prime recipient on an Office of Naval Research project grant for an IEEE Oceanic Engineering AUV 2026 Symposium, awarded August 17, 2026, and leads a current Air Force effort on highly efficient large-mode-area thulium-doped fibers for eye-safe laser systems, awarded September 1, 2025 (ultimate completion August 31, 2028).

In its subrecipient capacity, Southampton performs specialized scientific analysis and data interpretation across biomedical research programs. The institution provides mass spectrometric analysis of viral glycoproteins on a Fred Hutchinson Cancer Center-led NIH grant (June 28, 2024); conducts metabolomics assays and data analysis on a Dana-Farber Cancer Institute NMR research program (December 18, 2023); performs metabolomics analysis on a University of North Carolina at Chapel Hill-led grant studying bile acid profiles (February 14, 2023); carries out metabolomics assays on a University of Virginia-led study (December 7, 2023); and participates in a Johns Hopkins University-led investigation (November 25, 2024) involving data assembly and study analysis. Southampton also holds a subrecipient role on a Butler Hospital-led grant evaluating mindfulness-based therapy for serious mental illness in community mental health settings (October 31, 2025).

Activity has remained sparse and episodic — two awards in 2021, five in 2023, three in 2024, two in 2025, and one in 2026 — with only three awards reaching ultimate completion within the next twenty-four months.